Interestingly, Memo1 has been linked to NADPH oxidase activity in breast cancer cells (MacDonald et al., 2014), however the exact mechanism underlying these results, as well as a role for RhoA, has not been established and is likely to be context-dependent. This evidence concerns the gene FMO5 and breast carcinoma.